Receptor-interacting protein kinase 1 (RIPK1) and RIPK3 are members of the serine or threonine protein kinase superfamily that phosphorylates the hydroxyl group of serine or threonine through the highly conserved kinase region. The RIPK family plays a crucial role not only in inflammation and innate immunity, but also in mediating programmed cell death, such as apoptosis and necroptosis. The interaction between RIPK1 and other TNFR1-related proteins has been shown to assemble a signaling complex I that controls activation of the pro-survival transcription factor NF-κB upon binding of cytokines to TNF receptor 1 (TNFR1). Moreover, RIPK1 and RIPK3 interact through their RIP homotypic interaction motifs (RHIMs) to mediate programmed necrosis, which has long been considered an accidental and uncontrolled cell death form with morphological characteristics differing from those of apoptosis. Highly conserved sequences of RHIM in RIPK1 and RIPK3 were shown to regulate their binary interaction, leading to assembly of a cytosolic amyloid complex termed the "necrosome". The necrosome also contains mixed lineage kinase domain-like protein (MLKL), which has been found recently to be a substrate of RIPK3 to mediate downstream signaling. This review provides an overview of the functional and physiological characteristics of RIPKs and MLKL in TNF signaling.
Introduction
Stimulation of tumor necrosis factor (TNF)-like cytokines can initiate cellular signaling pathways that control homeostasis and viability in an organism [7, 40] . This stimulation is regulated by many protein complexes, including ligand-receptor complex, inhibitor κB kinase (IKK) complex, death-inducing signaling complex, apoptosome, necrosome, transforming growth factor beta-activated kinase-1 (TAK1)/ TAK1-binding protein 2/3, signaling complexes of death domain superfamily and other cytosolic complexes ( Fig. 1) [1, 7, 19, 26, 50] . Receptor interacting protein kinase (RIPK) 1 and RIPK3 are two of the most thoroughly investigated serine/threonine-protein kinases of the TNF-α signaling pathway. RIP kinases are central molecules for activation of the pro-survival transcription factor NF-κB that also regulate apoptotic and necrotic cell death. The extrinsic pathway of programmed cell death is mediated via diverse factors, such as the TNF receptor (TNFR), caspase and RIPK superfamily [9, 23, 38] .
The RIPK family members play an important role in TNF induced inflammation and other immune responses [12, 17] . They also have been shown to play a role in death receptor-dependent programmed cell death. Programmed cell death plays a key role in the elimination of reactive immune cells after massive clonal expansion in response to infection. Moreover, defects in normal programmed cell death mechanisms are related to autoimmune diseases, immunodeficiencies and cancer pathogenesis [10, 17, 34] . Apoptosis by cellular suicide mechanism is characterized by obvious morphological characteristics and energy dependent biochemical mechanisms, including cell shrinkage, DNA fragmentation, membrane blebbing and nuclear condensation [5] . Programmed cell death by the caspase-dependent pathway is triggered by extrinsic TNF-mediated signaling, whereas programmed necrosis via caspase-independent pathways is triggered when apoptosis is inhibited through cells that express mixed lineage kinase domain like protein (MLKL) and its up-regulators, such as RIPK3 [6, 47] .
Recently, a complex functional interplay between RIP1 and RIP3 has been identified as a form of programmed necrosis regulated through toll-like receptor or TNFR1. This region (also known as DD) [29, 47] . The interaction among these DD superfamily members has been shown to assemble a signaling complex I, which consists of the adaptor molecule TRAF-2 in lipid rafts on the plasma membrane [24, 35] .
The cellular inhibitor of apoptosis proteins 1 and 2(cIAP1 and 2) is also enlisted into signaling complex I, which per- and its interaction molecules lead to inhibition of NF-κB signaling and the formation of protein complexes that promote programmed apoptosis.
TNFR1-mediated programmed necrosis via RIPKs
and MLKL Necrotic cell death is considered an accidental and uncontrolled from of cell death with morphological characteristics differing from those of apoptosis. This unregulated process has been identified in numerous pathologies including ischemia-reperfusion injuries (brain, heart, kidney, and liver), eye diseases, brain trauma, acute inflammatory conditions, and viral infection [27, 32, 43] . Hallmarks of necrosis include swelling of the cytoplasm, endoplasmic reticulum, and mitochondria, with subsequent plasma membrane rupture [16] . Understanding of unique cellular events for necroptosis was initiated by the discovery that the RIPK1 is required for the necrosis of mouse embryonic fibroblasts (MEFs) through TNF signaling cascade [22] . Activation of RIPK1 and RIPK3 require auto/cross-phosphorylation and binary interaction through the RIP homotypic interaction motif (RHIM), which is the core domain that regulates necrotic cell death ( Fig.   2A ) [26] . Human RIPK1 encodes a protein composed of 671 amino acids with a kinase domain at the N-terminus and a C-terminal death domain. This domain is a conserved homology domain that acts as a protein interaction module containing a hexahelical bundle of 80 amino acids [36] . In addition to its N-and C-terminal domain, RIPK1 contains an intermediate domain that also retains a RHIM. Both RIPK1 and RIPK3 share a conserved motif, including kinase domain and RHIM, whereas RIP3 lacks the C-terminal death domain. Both serine/threonine kinase proteins are highly conserved, with 31%/53% sequence identity for the kinase domains of human RIPK1 and RIPK3, 77%/90% sequence identity for the kinase domains of human and mouse RIPK1, and 71%/81% sequence identity for the kinase domains of human and mouse RIPK3 (Fig. 2B) . Highly conserved isoleucine/valine-glutamine-isoleucine/leucine/valine-glycine sequences of RHIM in RIPK1 and RIPK3 were shown to regulate their binary interaction, which leads to assembly of a cytosolic amyloid signaling protein complex that has been called the 'necrosome' [26, 33] . The critical role of the RIPKs in programmed necrosis has been shown in cellular pro- [41, 52] . Recent cell studies suggest that activation results in plasma membrane translocation of trimerized MLKL protein, which promotes Ca 2+ and Na + influx, and eventually leads to membrane lysis [6, 8] . MLKL encodes a 471 amino acids protein with an N-terminal coiled-coil domain and a C-terminal kinase-like domain that is responsible for association with RIPK3. The interaction between MLKL and RIPK3 is dependent on RIPK3 kinase activity, and RIP3 needs to be phosphorylated at serine 227 of MLKL [41] . Conversely, RIPK3 phosphorylates MLKL at the threonine 357 and serine 358 sites in humans and serine 345, 347 and threonine 349 sites in mouse. Point mutation of MLKL phosphorylation sites or deletion of the MLKL inhibits programmed necrosis, but does not affect complex formation [9, 11, 21, 26, 47, 51] .
These results provide molecular and functional characterization of homotypic interaction motifs of RIPKs and its substrates, which are associated with programmed necrosis. 
